Lv51
870 积分 2021-12-16 加入
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
19天前
已完结
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies
19天前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
2个月前
已完结
Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer
4个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
4个月前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
5个月前
已完结
Lorlatinib Versus Crizotinib in Patients With Advanced ALK-Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
5个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
5个月前
已完结
Folinic Acid to Prevent Pemetrexed-Associated Neutropenia After Intrathecal Administration: A Quick Win
5个月前
已完结
Befotertinib: First Approval
6个月前
已完结
皖公网安备34019202002308
